par Björk, E;Kämpe, O;Karlsson, F A;Pipeleers, Daniel;Andersson, Ake;Hellerström, Claes;Eizirik, Decio L. 
Référence The Journal of clinical endocrinology and metabolism, 75, 6, page (1574-1576)
Publication Publié, 1992
Référence The Journal of clinical endocrinology and metabolism, 75, 6, page (1574-1576)
Publication Publié, 1992
Article révisé par les pairs
| Résumé : | Recent data suggest that the enzyme glutamic acid decarboxylase (GAD) may be a primary beta-cell antigen involved in the autoimmune response leading to insulin dependent diabetes mellitus (IDDM). Following three days culture of human islets at different glucose concentrations (5.6, 11 or 28 mM), there was a single 65 kDa/GAD band in the islet extracts, as assessed by immunoprecipitation both with serum from a newly diagnosed IDDM patient and a sheep anti-GAD serum. The synthesis of GAD was strongly stimulated at the higher glucose concentrations. Likewise, Western blot analysis indicated a glucose-induced increase of GAD in the islets. The data suggest that an enhanced function of human islet cells increases expression of GAD65. Possibly, this could exacerbate the autoimmune assault in the early stages of IDDM, and be of practical importance in attempts to ameliorate the autoimmune response towards the beta-cells in IDDM. |
